DEWB increases Net Asset Value in 2007 markedly and sets the course for further growth

- Net Asset Value per share increased to 3.03 Euros
- Assets under
Management raised to over 70 million Euros
- Photonics and sensor
systems share of the portfolio exceeds 50 percent
- Appointment of
the members of the Management Board extended

--------------------------------------------------------------------------------
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
the content of this announcement.
--------------------------------------------------------------------------------

balance

Jena (euro adhoc) - Key figures for DEWB 2007

2007 2006
Net Asset Value (NAV) per share 3.03 2.57
Assets under Management 71,234 51,177
Portfolio 40,565 40,818
Number of portfolio companies 10 12
New investments 3,869 9,009
Income from the investment business 12,614 17,707
Operating result (EBIT) 1,354 3,467

Jena, 28 February 2008 - Deutsche Effecten- und Wechsel-
Beteiligungsgesellschaft AG (DEWB) posted a profit for the 2007
business year. The company generated an income from the investment
business of 12.6 million Euros. The sale of EPIDAUROS Biotechnologie
AG accounted for 6.6 million Euros of this figure and 4flow AG, 5.6
million Euros. In the previous year the company achieved income from
sales of shares in the sum of 17.5 million Euros. The gross profit in
the investment business for 2007 totalled 2.6 million Euros (2006:
5.3 million Euros). Administrative expenses in the sum of 1.8 million
Euros showed a further reduction compared with 2006 (2006: 1.9
million Euros). DEWB was therefore able to markedly improve its
expense ratio related to the Assets under Management.

In the business year just past the company posted earnings from
operating activities (EBIT) of 1.4 million Euros (2006: 3.5 million
Euros) and earnings after taxes of 0.8 million Euros (2006: 3.2
million Euros). The Net Asset Value, as the key figure for the
development of value in the investment business, rose by 18 percent
from 39.2 to 46.2 million Euros; representing 3.03 Euros per share.
The increase was primarily attributable to a value adjustment of KSW
Microtec AG. The very positive development of the RFID company, in
which DEWB has a 100 percent stake, led to a six million Euro
increase in the book value, not affecting the income statement.
Assets under Management in 2007 rose to 71.2 million Euros against
51.2 million Euros in the previous year.

Forceful implementation of the growth strategy The chosen strategy of
focusing the investment portfolio on DEWB´s technological core areas
of expertise was pursued on a consistent basis by the company in the
business year just past. The investment in Zenteris GmbH in July 2007
was the first new commitment for three years and an investment in the
focused technologies photonics and sensor systems. At the same time
the company is gradually value enhanced disposing investments in
other fields of technology. With the sale of EPIDAUROS Biotechnologie
AG and 4flow AG, DEWB sold two companies from the biotechnology and
IT sector. In 2007 the company invested a total of approx. 3.9
million Euros in the investment business. Photonics and sensor
systems increased their share of the portfolio to over 50 percent.

Ideally positioned for the future The company continued to press
ahead with the reduction in debt during the 2007 business year. Bank
liabilities were nearly halved by 4.7 million Euros to 4.9 million
Euros. In the current business year the aim is to fully repay the
balance. The issue of a convertible bond in the sum of 20 million
Euros in October 2007, together with the inflows resulting from the
sale of investments, gave DEWB liquid assets in the sum of 21.4
million Euros (2006: 6.3 million Euros) as of 31 December 2007. The
company has therefore created the financial base so it can once again
take advantage of attractive investment opportunities within its
technology focus of photonics and sensor systems and markedly expand
its new business.

"Following completion of the `tidying-up´ exercise DEWB is now
ideally positioned for further growth. In KSW Microtec AG, one of the
leading manufacturers of RFID components and NOXXON Pharma AG, surely
at present the most promising German biotechnology company, we have
very exciting investments which offer significant potential for added
value", emphasises Bertram Köhler, member of the DEWB Management
Board. "In addition, we are investing in photonics and sensor
systems, one of the most exciting areas of technology for the future.
We are currently looking at a number of highly promising investment
opportunities and are already at an advanced stage of negotiations
with two companies", continues Köhler.

Outlook In 2008 photonics will be one of the key areas of investment
for the Venture Capital sector, as demonstrated by a current study
undertaken by FHP Private Equity Consultants and the magazine VDI
nachrichten. DEWB had already recognised the potential offered by
these technologies and taken a corresponding position early on. "We
are currently the only professional Venture Capital company in the
German-speaking region to have focused on photonics. In addition to
our extensive technological expertise we have a first class network
in the sector. This makes us the preferred partner for companies
seeking to raise capital and clearly sets us apart from our
competitors", says Köhler confidently.

DEWB aims to increase its Assets under Management above 100 million
Euros by 2010 by increasing the value of its investments and to
further establish itself as a leading venture capital provider for
companies in the photonics and sensor system area within the
German-speaking region. During this period the objective is to
achieve the increases in the value of the current portfolio companies
primarily through disposals that consequently affect the bottom line.
The cash earnings from these sales will be reinvested within the area
of our technology focus.

Management Board appointments extended At its meeting on 18 February
2008, the DEWB Supervisory Board extended the mandates of the members
of the Management Board Bertram Köhler, Falk Nuber and Mirko Wäckerle
for a three further years up to 31 December 2011 with effect from 1
January 2009. "The Supervisory Board is consequently rewarding them
for their successful work in the restructuring and strategic
realignment of the company. The extension of the mandates underlines
the confidence which the Supervisory Board has in the three members
of the Management Board and provides a long-term perspective for the
chosen growth strategy", stated Dr. Eckart von Reden, Chairman of the
DEWB Supervisory Board.

The 2007 Annual Report which is being published today will be
available for downloading on the DEWB website at www.dewb-vc.com. The
printed version of the report will be available from mid of March.

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: Deutsche Effecten- und Wechsel-Beteiligungsges. AG (DEWB)
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

Contact

Marco Scheidler

DEWB AG

Phone: +49 (0) 3641 573 3600

Fax: +49 (0) 3641 573 3610

E-Mail: ir@dewb-vc.com

www.dewb-vc.com

Branche: Financial & Business Services
ISIN: DE0008041005
WKN: 804100
Index: CDAX, Classic All Share, Prime All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse München / free trade